Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial
{{output}}
Background: Tubercular infection is highly prevalent in our country and conversion to tuberculosis disease is a major concern. Under the National Strategic Plan, India is heading towards ending tuberculosis by 2025. The benefits ... ...
